ESR1 and breast cancer: To demonstrate the generalizability of CASCAM beyond ILC samples, we applied the algorithm to three major molecular subtypes of breast cancer (HER2+, ER+/PR+/HER2- and TNBC) [45] using the TCGA and CCLE datasets.